VHL
VITASORA FPO [VHL]
Healthcare · ASX Small Cap
$0.0140 +7.7%
Updated 9 Sep 2026 · Signals refresh every scan
Appeared in 2 consecutive scansFirst seen: 2026-02-25
Get alerts when VHL triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- Above-average volume (1.7x) on a green day — buyers stepping up
- Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
- Drifting lower — down 6.7% over the last 5 days
- Beating the Small Ords index — relative strength of 1.20, so it's outpacing the pack
- Critical cash runway (1.2 quarters)
- Moderate P/S ratio (6.3x)
- EPS estimates revised upward (+10pts)
- Near 52-week low (13% of range)
- Small-cap ($20-100M)
- Capital raise activity (1 events)
- Sentiment is mixed — no strong consensus either way
- This one has been in freefall — down 56% over the past year
- The bigger volume days are the up days — volume-weighted momentum is positive (0.42%/day)
- Altman Z-Score distress zone (1.00 < 1.81, low-confidence approx)
- Penny stock risk ($0.013)
- RBA hiking (-3pts)
- Calendar: Clinical Trial in 6d (+5pts)
Risk Signals
- Below the 200-day average — the long-term trend is still working against it
- Revenue declining (-8%)
- Piotroski F-Score weak (3/9, low-confidence approx)
- Deeply negative margins (-219%)
- Not enough chatter to gauge sentiment — defaulting to neutral
Expected next for VHL
Window: 1 Jul to 31 Dec
From a company announcement on 26 Feb 2026
Each date is labelled with how it is known. A date estimated from past filings is inferred from this company's own filing rhythm — it is not a confirmed date and not a statement about what the company intends to do. See the whole ASX calendar →
Recent Catalysts
NONE Cleansing Notice
NONE Application for quotation of securities - VHL
NONE Appendix 4G and Corporate Governance Statement
LOW VHL 2026 Annual Report
Recent ASX Announcements
| 2026-09-03 | Cleansing Notice |
| 2026-09-03 | Application for quotation of securities - VHL |
| 2026-08-28 | Appendix 4G and Corporate Governance Statement |
| 2026-08-28 | VHL 2026 Annual Report |
| 2026-08-28 | June 2026 Appendix 4E PRICE SENSITIVE |
Key Metrics
$30.5M
Market Cap
1.3M
Avg Volume
1.7x
Vol Ratio
$0.01 — $0.04
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-70.3%
ROE
-219.2%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 72% |
| L | Leader vs Laggard | laggard | RS: -13 |
| I | Institutional Sponsorship | weak | Inst: 9% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
110 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track VHL and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required